KOCAA
CGON icon

Knights of Columbus Asset Advisors’s CG Oncology CGON Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Sell
20,870
-2,330
-10% -$152K 0.07% 249
2026
Q1 		$1.57M Buy
23,200
+5,400
+30% +$306K 0.09% 224
2025
Q4 		$739K Buy
+17,800
New +$737K 0.04% 278

Other funds holding CGON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Knights of Columbus Asset Advisors's CGON Position: Q2 2026 in Review

Knights of Columbus Asset Advisors reduced its CG Oncology (CGON) stake by 10% in Q2 2026, selling an estimated $152K and leaving 20,870 shares worth $1.48M. The position accounts for 0.07% of the portfolio, ranked #249.

Knights of Columbus Asset Advisors first reported a position in CGON in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.57M in Q1 2026. 71 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Knights of Columbus Asset Advisors held 20,870 shares of CG Oncology worth $1.48M as of Q2 2026.
  • Knights of Columbus Asset Advisors sold 2,330 CG Oncology shares in Q2 2026, an estimated $152K.
  • CG Oncology made up 0.07% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #249 holding.
  • Knights of Columbus Asset Advisors first reported a position in CG Oncology in Q4 2025 and has held it in 3 quarters since.
  • Knights of Columbus Asset Advisors's CG Oncology position peaked at $1.57M in Q1 2026.
  • 71 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.